Research reportCombining psychotherapy and antidepressants in the treatment of depression
Introduction
Many clinicians are convinced that combined therapy, i.e., psychotherapy plus antidepressants, is the treatment of choice for ambulatory patients suffering from depression. They believe that, in these patients, combined therapy is more efficacious than one of its components, psychotherapy or antidepressants alone. These views, however, are not supported by empirical evidence. A Medline search of literature revealed four reviews of studies comparing combined therapy with antidepressants and/or with psychotherapy Conte et al., 1986, Robinson et al., 1990, Wexler and Cicchetti, 1992, Manning et al., 1992. There is, of course, considerable overlap between these four reviews which actually cover thirteen separate articles. The general conclusion is: “On most measures in most studies, the effect of combined therapy equals either psychotherapy or pharmacotherapy alone, whereas in some studies, the combination shows some superiority” (Manning and Frances, 1991). The thoroughness of a fifth review means that it deserves special attention (U.S. Department of Health and Human Services, 1993). It reports on mean short-term intent-to-treat response rates. The rate is 51.2% in patients treated with tricyclic antidepressants (102 studies) and 47.4% in patients treated with selective serotonin reuptake inhibitors (39 studies). The excess response rate over placebo is 21.3% for TCAs (46 studies) and 20.1% for SSRIs (23 studies). The response rate is 46.6% for cognitive therapy (22 studies), 55.3% for behaviour therapy (13 studies), 34.8% for brief dynamic therapy (8 studies) and 52.3% for interpersonal therapy (1 study). It is 34.6% in patients treated with a combination of behaviour therapy and antidepressants (2 studies), and 53.7% in patients treated with a combination of cognitive therapy with antidepressants (5 studies). These results indicate that both antidepressants and psychotherapy are efficacious treatments in ambulatory depressed patients, but the combination does not seem to offer any advantage. A “mega-analysis”, or meta-analysis of original data, of 595 patients with major depressive disorder enrolled in 6 standardized treatment protocols found new evidence in support of the widespread clinical impression that combined therapy is superior to psychotherapy alone for treatment of more severe, recurrent depressions, but not for the treatment of less severely depressed patients (Thase et al., 1997). In short, the strong convictions of clinicians and the hard data of researchers are difficult to reconcile on this topic. This article reports on the results of a randomised clinical trial comparing the efficacy of combined therapy with that of antidepressants alone in a six-month treatment programme for ambulatory patients with DSM-III-R-defined Major Depression, presenting a 17-item Hamilton Depression Rating Scale (HDRS) (Hamilton, 1967) baseline score of at least 14 points.
Section snippets
Study group
The study sample consists of all consecutive patients newly registered during a period of two years at an outpatient clinic of the Psychiatrisch Ziekenhuis Amsterdam in the inner city of Amsterdam. There are 4 inclusion criteria and 9 exclusion criteria. The inclusion criteria are: age between 18 and 60 years, DSM-III-R-defined Major Depression (with or without dysthymia), a 17-item HDRS baseline score of at least 14 points and written informed consent. The exclusion criteria were: presentation
Results
A total of 167 patients are randomised (pharmacotherapy N=84; combined therapy N=83) using block randomisation. Four blocks are formed, defined by sex and age. Of the randomised patients, 38 patients refuse the proposed treatment: 27 in the pharmacotherapy and 11 in the combined therapy group. This difference for the refusals between the two conditions is significant (chi-square=9.572, df=2, P=0.008).
The group which actually starts the treatment therefore consists of 129 patients: 57 in the
Discussion
Until now, very few studies have been undertaken of brief psychodynamic psychotherapy, either alone or in combination with medication. This study addresses the pragmatic question of differential clinical utility of two fully operational treatment programmes, both representative of actual clinical practice. It must be made clear that the results do not constitute evidence that SPSP, which is applied here in combination with pharmacotherapy, is in itself an effective form of psychotherapy. The
Conclusion
Patients found combined treatment significantly more acceptable, they were significantly less likely to drop out of combined therapy and, ultimately, significantly more likely to recover. In this study, the excess remission rate of combined therapy (psychotherapy plus antidepressants) over pharmacotherapy is approximately 20% after 24 weeks of treatment. This equals the excess success rate of pharmacotherapy over placebo in short time studies. Combined therapy seems preferable to
Acknowledgements
This study has been supported by an unrestricted educational grant from Eli Lilly Nederland. It has been carried out by the Mentrum Depression Research Group.
References (21)
- et al.
SCL-90. Handleiding bij een multidimensionele psychopathologie-indicator
(1986) - et al.
Combined psychotherapy and farmacotherapy for depression
Arch. Gen. Psychiat.
(1986) Leidraad voor het scoren van de Hamilton Depression Rating Scale
(1994)- et al.
Psychoanalytic supportive psychotherapy
J. Am. Psychoanal. Assoc.
(1994) - et al.
National Institute of Mental Health treatment of depression colloborative research program: general effectiveness of treatments
Arch. Gen. Psychiat.
(1989) ECDEU Assessment Manual for Psychopharmacology
(1976)Development of a rating scale for primary depressive illness
Br. J. Soc. Clin. Psychol.
(1967)- et al.
Cognitive Therapy of Depression: Conceptual Issues and Clinical Efficacy
J. Consult. Clin. Psychol.
(1993) - et al.
Research considerations in evaluating combined treatment
- et al.
The Manual for the Diagnosis of Major Depression (MDMD): description and reliability
Int. J. Meth. Psychiatr. Res.
(1996)
Cited by (172)
The efficacy of psychodynamic psychotherapy: An up-to-date review
2019, Contemporary Psychodynamic Psychotherapy: Evolving Clinical PracticePsychological intervention combined with direct electrical brain stimulation (PIN-CODES) for treating major depression: A pre-test, post-test, follow-up pilot study
2017, Neurology Psychiatry and Brain ResearchEfficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: Results of a randomized controlled trial
2017, Journal of Affective DisordersCombining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects
2016, Journal of Affective Disorders